touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond
Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
Addressing the diagnosis and management of pet allergies in primary care and beyond
Addressing the diagnosis and management of pet allergies in primary care and beyond
touchHAEMATOLOGY - The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
touchONCOLOGY - The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
touchIMMUNOLOGY - Diagnosing and treating patients with EoE: Tackling the difficulties
touchRESPIRATORY - Diagnosing and treating patients with EoE: Tackling the difficulties
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3
touchMDT – Management of prurigo nodularis – Discussion 2
touchMDT – Burden of prurigo nodularis – Discussion 1
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3
touchMDT – Management of prurigo nodularis – Discussion 2
touchMDT – Burden of prurigo nodularis – Discussion 1
Is HER2 targeting on the horizon for urothelial carcinoma?
Addressing challenges in diagnosis and treatment of IgG4-related gastrointestinal disease
Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL
Haemato-oncology experts discuss current considerations and future strategies for CAR T-cell therapies in patients with R/R MCL
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain